We develop innovative delivery
technologies that can be employed
for various gene therapeutics.
Stability Enhanced Nano Shell
for Tissue-selective Delivery
DDS that protects and delivers nucleic acids with superior stability and tissue-selectivity
What is SENS™ Platform?
SENS™ is Samyang’s proprietary gene delivery technology that uses novel cationic lipids and biodegradable polymers.
The cationic lipids discovered by Samyang protect the nucleic acid effectively and provide tissue selectivity. Biodegradable polymer components provide structural stability of the nanoparticle for blood circulation and ensure a high level of safety.
Samyang offers diverse DDS solutions through a library of novel components and formulations.
Team of ExpertsDecades of experience in biodegradable polymer production and process development
Novel CompoundsDiscovery of new compounds through rational design and AI-driven analytics/databases
Formulation DevelopmentFormulation development and production
Gene TherapyDevelopment of RNA therapeutics through partnership
Based on 30+ years of R&D experience in drug delivery system, we are accelerating the development of our gene delivery technology, SENS™
We supply compounds with high gene-delivery efficiency and safety.
We offer a library of tissue-selective formulation and production/process development technologies.
Samyang’s SENS™ will continue to advance and become the core technology leading the global gene therapy market, contributing to improving human health worldwide.